Directorate of Research
Contact:
(02164) 241555 / 241556 / 241557 / 241558
Vision
To emerge as a centre of excellence for conduction of good quality, interdisciplinary,
innovative, basic as well as applied research with emphasis on need based and translational
research
Mission
- The KIMS “Deemed To Be University” shall foster interdisciplinary research that will generate meaningful outcomes for the community and the nation
- It shall provide translational research abilities for improving health care of the needy, socio economically deprived urban and rural populations
- It shall seek collaborations of national and international research institutes for conducting good quality research to provide solutions to the problems faced by the community at local as well as state, National and International level
Objectives
- To conduct Training workshops (Research Methodology, IPR, GCP, GCLP)
- To undertake multiple scrutiny of all research proposals
- To obtain approval from IEC for all research projects
- To sanction funds for implementation of research proposals
- To monitor the quality of research work continuously
- To encourage researchers to obtain funds from external agencies
- To increase publications in the reputed, indexed journals
- To encourage & guide staff to apply for patents & copy rights
- To encourage learners & staff to organize & participate in Conferences & Workshops
- To encourage staff to write books & book chapters
- To publish quarterly Journal of Krishna Institute of Medical Sciences University
Directorate of Research Staff
Dr. A. R. Risbud
Director of Research
Dr. D. K. Agarwal
Add. Director of Research
Dr. A. J. Patil
Dy. Director of Research
Dr. S. V. Kakade
Assist. Director Research
Dr. J. R. Pawar
Research Associate
Dr. R. S. Phatak
Research Associate
Mrs. T. S. Bhosale
Research Associate
Mr. D. A. Mane
Research Associate
Mr. M. M. Alate
Research Associate
Smt. Nandinee Chavan
Clerk
Mr. D. M. Pawar
Office Attendant
LEAD REFERRAL LABORATORY
- Lead referral laboratory (1st of it’s kind in Maharashtra) established on 9th Feb 2012 at Department of Biochemistry, KIMSDU, Karad, with collaboration of National Referral Centre for Lead Projects of India, Bangalore and Indian Society of Lead Awareness and Research
- Recognized by the WHO as a Rural Lead Referral Centre
Molecular Biology and Genetic Laboratory
VIROLOGY Laboratory
Research collaborations
Activities under foreign collaborations
| Sr. No. | Collaboration | Activity |
|---|---|---|
| 1 | Uniformed Services University of Health Sciences, Bethesda, USA (USHUS) | Learners from USUHS are participating in month long electives in Tropical Medicine and various subjects |
| 2 | St. Georges University, Grenada | Learners from SGU are participating in two week / one month long electives |
| 3 | John Hopkins Institute, USA | The John Hopkin center of excellence ( CCGHE) supports clinical care and research training to Government and private institutions in India on HIV projects and research capacity building. KIMSDU is one of the participants. |
| 4 | St. Georges University, Grenada | Medical experience elective |
| 5 | Joint project with Dr. Gerald Quinnan (USUHS) | A joint research proposal on TB has been submitted to National Institutes of Health, USA . |
| 6 | American Heart Association Project SEVAK |
Two individuals from rural and urban slum area of Karad are trained by the American Heart Association for the cause ‘Save Children Lives’ (SCL). They are creating awareness among the residents about importance of safe practices of sanitation and are collecting relevant data |
| 7 | Academic Mission Cooperation with Walter Reed Army Medical Centre, Washington DC, USA | Research collaborative studies are being planned |
Research Collaborations with national Institution
| 1 |
Indian Council Of Medical Research National AIDS Research Institute, Pune- NARRIM Project National Institute of Epidemiology , Chennai- Support for protocol development National Institute of Virology, Pune- Rota Virus, H1N1, SARS, MERS, SARS-CoV 2 studies |
| 2 | Moving Academy of Medicine & Biomedicine, Pune. Student training |
| 3 | Department of Health Sciences, University of Pune. IPR related activity |
| 4 |
Defense Institute of Advanced Technology, Pune. Collaborative studies- Title: Chitosan based hydrogel nanoparticles for applications in wound healing (Joint application to DBT) Title: A step towards use of Polysulfone based composite hollow fiber membranes as immunoisolation device for bioartificial pancreas |
| 5 | Govt. of Maharashtra has identified KIMSDU for training of their staff and for collaborative research studies. |
| 6 | Indian Society of Lead Awareness and Research- KIMSDU lab has been recognised as National Lead referral laboratory. Research studies conducted have resulted in 18 publications and three PhD studies |
| 7 |
Maharashtra State AIDS Control Society (MSACS): Prevention of Parent to Child Transmission (PPCT) & Anti-Retroviral Treatment (ART) center at KIMSDU |
| 8 | ‘Ehsaas’ special school for Mentally Handicapped, Shendre, Satara- KIMSDU staff is engaged in providing health care services & research |
| 9 | College of Engineering, Pune- Student Exchange, support for prototype development |
| 10 | Rajarambapu Institute of Technology, Sakharale- Academic activities |
| 11 | Bharti Vidyapeeth’s Yashwantrao Mohite Institute of Management for Academic Collaboration |
| 12 | Indira Gandhi Institute of Development Research, Mumbai- Library Activities |
| 13 | Veritas Bioventions PVT LTD – Technology Cooperation |
| 14 | Vansh a branch of Pishwikar Hospital, Kolhapur- Collaboration for post doctoral fellowship |
| 15 | Ranganath Hospital and Laparoscopic Academy, Kolhapur- Collaboration for post doctoral fellowship |
| 16 | Society for Research and Reproduction Medicine, Kolhapur- Collaboration for post doctoral fellowship |
| 17 | Bel- Air Hospital of Indian Red Cross Society, Panchgani- Nursing Experience Program , student exchange |
| 18 | “AARAMBH Center for Autism and Slow Learners” Aurangabad – to work with children with multiple disabilities like mentally challenged, Autism, ADHD, Cerebral Palsy, Slow learners and behavior problems with AARAMBH Centre |
| 19 | Insight CBCT Imaging – Students training |
| 20 | Datta Meghe Institute of Medical Sciences (Deemed To Be University) (DMIMSDU), Atre Layout, Nagpur –Training |
| 21 | MOU Between KIMSDU, Maharashtra University of Health Sciences (MUHS) Nashik, Training |
| 22 | MOU Between KIMSDU, Sanjeevani Institute, Karad |
| 23 | MOU Between KIMSDU, Government College of Engineering, Karad, prototype preparation |
| 24 | MOU Between KIMSDU, Richardson Leprosy Hospital, Tal. Miraj, Dist. Sangli, student training |
| 25 | MOU Between KIMSDU, OpEx Accelerator Private Limited, Kolhapur, IPR training |
| 26 | MOU Between KIMSDU, GI India Automation & Systems Pvt. Ltd., Pune, India, Prototype designing |
| 27 | MOU Between KIMSDU, RiddhiSurgicals, Mumbai, India, Startup |
| 28 | MOU Between KIMSDU and Paradise Plastic Molding Works, Karad, India,Startup |
| 29 | MOU Between KIMSDU, GSR Institute of Craniomaxillofacial& Facial Plastic Surgery, Hyderabad, Telangana, India. Dental student Training |
| 30 | MOU Between KIMSDU and P.G. Department of Zoology and Research Centre, Shri Shiv Chhatrapati College of Arts, Commerce and Science, Bodkenagar, Junnar, Maharashtra, India. Research study |
| 31 | MOU Between KIMSDU and R2E Technologies Private Limited (Tech Councellor) Kotdwar, Uttarakhand. Joint collaboration for IPR related activities |
| 32 | MOU Between KIMSDU and Maharashtra Education Society (MES), College of Nursing, Lote Parsuram, Student exchane & traning |
| 33 | MOU Between KIMSDU and National Entrepreneurship Network, 7th Floor, Building No. 11, Solitaire Corporate Park, Andheri East, Mumbai, Maharashtra, India., Research study |
| 34 | MOU Between KIMSDU and Bulehora University, Ethiopia, East Africa, Nursing research |
| 35 | MoU between Krishna Institute of Pharmacy and Bapuji Pharmacy College, Davangere, collaborative research |
| 36 | MoU between Krishna Institute of Pharmacy and KLE College of Pharmacy, Hubballi |
| 37 | MoU between Krishna Institute of Pharmacy and JSS Academy of Technical Education, Noida, Collaborative research |
| 38 | MoU between Krishna Institute of Pharmacy and Indrayani Institute of Pharmaceutical Education and Research, Pune, Nursing Research |
| 39 | MoU between Krishna Institute of Pharmacy and Maratha Mandal’s College of Pharmacy, Belagavi, Collaborative Research |
Research outcomes
Number of research papers published in the approved list of Journals indexed in Scopus/Web of Science/Pub Med
| Year | Staff | Learners |
|---|---|---|
| October 2012 | 32 | 138 |
| September 2013 | 02 | 100 |
| August 2014 | 22 | 101 |
| September 2015 | 09 | 110 |
| August 2016 | 05 | 120 |
| October 2017 | 02 | 119 |
| October 2018 | 00 | 223 |
| December 2019 | 08 | 126 |
| November 2020 (Online) | 25 | 809 |
| Total | 105 | 1846 |
| Year | Scopus | Web of Science | PubMed |
UGC listed Journals |
|---|---|---|---|---|
| 2015 | 100 | 45 | 46 | 189 |
| 2016 | 105 | 74 | 41 | 153 |
| 2017 | 74 | 51 | 43 | 105 |
| 2018 | 70 | 44 | 33 | 94 |
| 2019 | 146 | 53 | 26 | 176 |
| 2020 | 486 | 97 | 58 | 533 |
| Total | 981 | 364 | 247 | 1250 |
|
Calendar Years |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total |
|---|---|---|---|---|---|---|---|
| Number of research papers | 385 | 366 | 348 | 310 | 382 | 574 | 2365 |
Citation Index in Scopus/ Web of Science
Formula:
0.5 x Total number of Citations SCOPUS in five years + 0.5 x Total number of Citations in Web of Science in five years/ 0.5 x Total number of Publications in SCOPUS in five years + 0.5 x Total number of Publications in Web of Science in last five calendar years
=Average Citation index
= 0.5 x 6343 + 0.5 x 5,513 / 0.5 x 947 + 0.5 x 76
= 3171.5 + 2756.5 / 473.5 + 38
= 5928 511.5
Average Citation Index = 11.58
Scopus/ Web of Science – h-index of the Institution
Formula:
= h – Index of Scopus + h – Index of Web of Science in the last 5 calendar years / 2
= h– Index of the Institution
= 26.52 + 12 / 2
= 19.26
h– Index of the Institution = 19.26
|
2015- 2016 |
2016- 2017 |
2017- 2018 |
2018- 2019 |
2019- 2020 |
Total | |
|---|---|---|---|---|---|---|
|
Patent and Design Granted |
0 | 0 | 5 | 2 | 16 | 23 |
|
Patent Published |
0 | 2 | 2 | 5 | 26 | 35 |
|
Copyright Awarded |
0 | 5 | 1 | 44 | 227 | 277 |
|
Technology- transfer |
0 | 0 | 0 | 0 | 7 | 7 |
| Total | 0 | 7 | 8 | 51 | 276 | 342 |
| Calendar Years |
July 2015 |
2016 | 2017 | 2018 | 2019 | 2020 | Total | |
|---|---|---|---|---|---|---|---|---|
|
Number of Books |
2 | 1 | 4 | 1 | 16 | 11 | 35 | |
|
Number of Chapters |
1 | 3 | - | 1 | 112 | 9 | 126 | |
|
Papers in National/International Conference- Proceedings |
28 | 21 | 10 | 36 | 35 | 12 | 142 |
| Degrees |
2015- 2016 |
2016- 2017 |
2017- 2018 |
2018- 2019 |
2019- 2020 |
Total |
|---|---|---|---|---|---|---|
| Ph.D.s | 04 | 11 | 07 | 14 | 11 | 47 |
| PG | 89 | 111 | 85 | 129 | 167 | 581 |
| DM | - | - | - | - | - | - |
| M. Ch | - | - | 1 | 1 | 1 | 3 |
| Total | 93 | 122 | 93 | 144 | 179 | 631 |
Research Grants
|
Name of the Project/ Clinical Trial/ Endowment/ Chairs |
Name of the Principal Investigator/ CoInvestigator |
Name of the Funding agency |
Type (Government/ Non-Government etc., ) |
Department of Principal Investigator/ Co Investigator |
Year of Award |
Funds provided (INR in Lakhs) |
Duration of the project |
| Integrated Counselling and Testing centre (ICTC) |
1) Dr. Asha Jadhav, 2) Dr. S. R. Patil |
Maharashtra State AIDS Control Society, (MSACS), Mumbai. under National Aids Control Organization (NACO) |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2015 | 12.77 | 2015-2016 |
|
Cross Sectional Study on the Health Related Quality of Life in Patients Who Complete Treatment for Pulmonary Tuberculosis |
Dr. Vijay D. Nair |
Revised National TB Control Programme (RNTCP) |
Government |
TB Chest |
2016 | 0.24 | 2016-2017 |
| Identifying predictors of treatment outcome in Tuberculosis |
Dr. Asha K. Pratinidhi. |
Revised National TB Control Programme (RNTCP) |
Government |
Directorate of Research |
2016 | 1.26 | 2016-2017 |
|
Tuberculosis Case Detection in High risk Population in context to Migrants |
Dr. Vaishali V. Raje |
Revised National TB Control Programme (RNTCP) |
Government |
Preventive and Social Medicine |
2016 | 1.08 | 2016-2017 |
| Integrated Counselling and Testing centre (ICTC) |
1) Dr. Asha Jadhav 2) Dr. S. R. Patil |
Maharashtra State AIDS Control Society, (MSACS), Mumbai. under National Aids Control Organization (NACO) |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2016 | 15.20 | 2016-2017 |
|
(Phase II) Promoting HIV Vaccine research and development through tech-transfer andcapacity building for HIVimmune- pathogenesis studies- |
1) Dr. Asha Jadhav 2) Dr. G.S. Karande |
International AIDS Vaccine Initiative (IAVI, USA), Indian Council of Medical Research |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2017 | 49.14 | 2017-2019 |
| Integrated Counselling and Testing centre (ICTC) |
1) Dr. Asha Jadhav 2) Dr. S. R. Patil |
Maharashtra State AIDS Control Society, (MSACS), Mumbai. under National Aids Control Organization (NACO) |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2017 | 18.81 | 2017-2018 |
| Integrated Counselling and Testing centre (ICTC) |
1) Dr. Asha Jadhav 2) Dr. S. R. Patil |
Maharashtra State AIDS Control Society, (MSACS), Mumbai. under National Aids Control Organization (NACO) |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2018 | 22.90 | 2018-2019 |
|
Health study to assess the impact of water pollution on water born disease |
Dr. Shivkumar KM |
Council of Scientific Industrial Research (CSIR)– National Environmental Engineering Research Institute (CSIR-NEERI), Mumbai. |
Government |
Public Health Dentistry |
2018 | 3.23 | 2018-2019 |
| COHRPICA study-Cohort for HIV Resistance and Progression in Indian Children & Adults |
1) Dr. Asha Jadhav 2) Dr. A.R. Risbud 3) Dr. S.S. Patil 4) Dr. G.S. Karande 5) Dr. R. P. Patange |
International AIDS Vaccine Initiative (IAVI, USA), Indian Council of Medical Research Department of Biotechnology, GOI |
Government |
1) Obstetrics & gynaecology 2) Directorate of Research, 3) PSM, 4) Microbiology |
2018 | 15.84 | 2018-2023 |
| Integrated Counselling and Testing centre (ICTC) |
1) Dr. Asha Jadhav 2)) Dr. S. R. Patil |
Maharashtra State AIDS Control Society, (MSACS), Mumbai. under National Aids Control Organization (NACO) |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2019 | 19.21 | 2019-2020 |
|
Implementation and Evaluation of Community Based Intervention for Upliftment and Voluntary Participation in Biomedical Research |
1) Dr. Asha Jadhav 2) Dr. G.S. Karande 3) Dr. R. P. Patange |
International AIDS Vaccine Initiative (IAVI, USA), NARI |
Government |
1) Obstetrics & gynaecology 2) Microbiology |
2019 | 41.91 | 2019-2020 |
|
Genetic Polymorphisms and Genomic determinats of acute normal tissue toxicity after radiotherapy for head and neck malignancy |
1) Dr. Anand K. Gudur 2) Dr. Kailas D. Datkhile |
Indian Council of Medical Research (ICMR |
Government |
1) Oncology 2) Molecular Biology & Genetics |
2019 | 15.8 | 2019-2021 |
| Sr. No. |
Name of the Project/ Clinical Trial / Endowment/ Chairs |
Name of the Principal Investigator/ Co-Investigator |
Name of the Funding agency |
Type (Government/ Non-Government etc., ) |
Department of Principal Investigator/ Co Investigator |
Year of Award |
Funds provided (INR in Lakhs) |
Duration of the project |
| 1 |
Estimation of lead from water, cosmetics, paints and traditional medicine |
Dr. Arun Patil |
UL-Underwriters Laboratories (USA) funds sanctioned to InSLAR & NRCLPI |
Non -Government |
Biochemistry | 2015 | 5 | 2015-2016 |
| 2 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome |
1) Dr. Aparna Patange, 2) Dr. Shilpa Patil |
Sonofi India Pvt Ltd |
Non Government |
Medicine | 2015 | 9.6 | 2015-2017 |
| 3 |
“Evaluation of Efficasy and Safety of Fixed Dose Combination of Losartan, Amlodipine and Hydrochlorothiazide in The Treatment of Essential Hypertension: An Open Label, Multi-Centric Trial |
1). Dr. Aparna Patange 2).Dr. R.G. Naniwadikar |
Sun Pharma |
Non Government |
1). Medicine 2). Surgery |
2015 | 8.5 | 2015-2016 |
| 4 |
A Phase IV, Non- Inferiority, Observe Blind, Randomized Clinical Study comparing safety and Immunogenicity of Measles- Mumps- Rubella (MMR) Subcutaneous Vaccination by Disposable –Syringe Jet Injector to Vaccination by Needle and Syringe for the Administration in Healthy Children in India aged 15 to 18 months |
Dr. C. D. Aundhkar |
Serum Institute of India Limited, Pune and Diagno Search Life Sciences LTD, Thane |
Non Government |
Pediatrics | 2015 | 1.41 | 2015-2016 |
| 5 |
“Evaluation of Efficasy and Safety of Fixed Dose Combination of Losartan, Amlodipine and Hydrochlorothiazide in The Treatment of Essential Hypertension: An Open Label, Multi-Centric Trial |
1). Dr. Aparna Patange 2).Dr. R.G. Naniwadikar |
Sun Pharma |
Non Government |
1). Medicine 2). Surgery |
2016 | 0.15 | 2016-2017 |
| 6 |
Protocol 0927-17: A multicentre, open label, Randomized, Two treatment, Two period, Two-sequence, Single dose, Cross-Over, Study to Test for Bioequivalence between Celeritys Doxorubicin Hydrochloride (Pegylated Liposomal) Injection 20mg/10mL(2mg/mL) and the Reference product, Caelyx®[Doxorubicin Hydrochloride (pegylated liposomal)Injection 20mg/10mL)(2mg/mL)] in Patients with Metastatic Breast Cancer |
1). Dr. Anand Gudur 2). Dr. Rashmi A. Gudur |
Celerity Pharmaceuticals, LLC 9450 W. Bryn Mawr Ave., Suite 640, Rosemont, IL 60018. Tel. No.: +1(847) 999-0477 Email: buchil@celeritypharma.com |
Non Government |
Radiotherapy | 2018 | 3.34 |
2018 -2020 |
| 7 |
A Research On Currently Available And Novel Anti-Cancer Agents On Fresh Surplus Tissues Primarily Using CANSCRIPT ™ Technology |
Dr. Anand Gudur Dr. Digvijay Patil |
Bio Mitra Pharmaceuticals through CRO Lambda |
Non Government |
Radiotherapy | 2019 | 1.12 | 2019-2020 |
| 8 |
A global, multicentre, three arms, open-label randomized study to evaluate the efficacy and safety of Nanosomal Docetaxel Lipid Suspension compared to Taxotere® (Docetaxel Injection Concentrate) in triple-negative breast cancer patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy |
Dr. Anand Gudur Dr. Rashmi A. Gudur |
Intas Pharmaceuticals through CRO Lambda |
Non Government |
Radiotherapy | 2019 | 0.8 | 2019-2021 |
| 9 |
A Cross-sectional Multicenter, Epidemiological Study to Evaluate the Clinicodemographic Profile and Management Practices for Primary Prophylaxis of Overt Hepatic Encephalopathy in Patients with Cirrhosis in India |
Dr. Sandeep Patil |
Abott |
Non Government |
Medicine (Gastroenterologist) |
2019 | 0.75 | 2019-2020 |
| 10 |
A Prospective, Randomized, Parallel Group, Double Blind, Multicentre study to compare the efficacy, safety and immunogenicity of Lupins Ranidizumab with Lucentis in patients with neovascular age related macular degeneration |
1). Dr.Gaurav Paranjpe 2). Dr. Prajakta Patil |
Lupin |
Non Government |
Ophthalmology | 2019 | 5.9 | 2019-2020 |
| 11 |
A Multicentre Phase III, Double blinded, Randomized Placebo controlled study to evaluate the efficacy of Recombinant BCGVPM 1002 in reducing infection incidence and disease severityof SARS- COV-2/COVID-19 among high risk subjects |
1). Dr. Sujata Patil, 2). Dr Sujata jadav 3). Dr.Aparna Patange |
Serum Institute of India PVT, LTD |
Non Government |
1). PSM, 2). Pharmacology 3). Medicine |
2020 | 16.37 |
2019- 2020 |
| 12 |
Prevalence of Metabolic Syndrome And Related Risk Factors In Bank Employees of Western Maharashtra, India |
Dr. Jyotsna Arun Patil |
Krishna Sahakari Bank Ltd |
Non Government |
Biochemistry | 2020 | 10 |
2020- 2021 |
| 13 |
Effectiveness of early ambulation with indigenously prepared harness sling on functional independency in incomplete spinal cord injury |
Dr. Suraj Kanase |
Shree Diliprao dadasahebrao chavan |
Non Government |
Neurosciences | 2020 | 1.65 |
2020 -2021 |
| 14 |
Effect of multicomponent exercise program on functional performance in post coronary artery bypass grafting individuals amongst rural population |
Dr. Chandrakant Patil |
Shree Diliprao dadasahebrao chavan |
Non Government |
Cardio-pulmonary Sciences |
2020 | 5.29 |
2020 -2021 |
| 15 |
Design and Development of Anti-virulent Face Mask to Improve the Disease Combat Efficiency of Patients and Medical Practitioners against COVID-19 and other Contagious Diseases |
Dr. Jayant Pawar |
Shree Dhanlaxmi Foundation, Karad |
Non Government |
Directorate of Research |
2020 | 1.2 | 2020-2021 |
| 16 |
Outcome prediction and severity of corona virus disease (covid-19) on the basis of clinical and laboratory parameters |
Dr. Virendra Patil |
Shree Amit Diliprao Chavan |
Non Government |
Medicine | 2020 | 3.19 |
2020 -2021 |
| 17 |
Maternal and Foetal Outcome among Antenatal Cases with Covid-19 Admitted in a Tertiary Care Hospital in Karad- a Prospective Study |
Dr. Sanjay Patil |
Shree Dhanlaxmi Foundation, Karad |
Non Government |
ObG / Gyn |
2020 | 3.8 |
2020 – 2021 |
| 18 |
Study of SARS-CoV2 virus positivity rate among patients attending Krishna Hospital & Medical Research Center- ‘A Dedicated COVID Hospital’ |
Dr. Satish R. Patil |
Shree Dhanlaxmi Foundation, Karad |
Non Government |
Microbiology | 2020 | 5 |
2020 – 2021 |
| 19 |
A Clinical Trial to study effect of high dose vitamin C on clinical outcomes in patients infected with corona virus- 2019 (COVID-9) |
Dr. Archana Gautam |
Anand Life Sciences, Pharmaceutical Co. Belgaum |
Non Government |
Critical Care |
2020 | 0.34 |
2020 – 2021 |
| 20 |
Study of Serum Vitamin D Levels and Disease Outcome in Covid – 19 Patients |
Dr. Mrs. Sujata Jadahv |
Shree Amit Diliprao chavan |
Non Government |
Pharmacology | 2020 | 0.92 |
2020 – 2021 |
| 21 |
Prevalence and drug utilization pattern in comorbid cases of corona virus disease (COVID-19): A Retrospective study |
Dr. Mrs. Seshla Sadanandan |
Anand Life Sciences, Pharmaceutical Co. Belgaum |
Non Government |
Pharmacology | 2020 | 0.034 |
2020 – 2021 |
| 22 |
A Study on Serum Ferritin And D-Dimer Levels in Covid-19 Positive Patients |
Dr. Mrs. Aparna Patange |
Shree Amit Diliprao chavan |
Non Government |
Medicine | 2020 | 0.67 |
2020 -2021 |
| 23 |
A Study of Pulmonary Function Test in Stage I and Stage II COVID 19 Positive Patients |
Dr. Mrs. Aparna Patange |
Anand Life Sciences, Pharmaceutical Co. Belgaum |
Non Government |
Medicine | 2020 | 0.07 |
2020 -2021 |
| 24 |
Study of ABO group susceptibility to corona virus disease (COVID 19) |
Dr. Sushma Bommanavar |
Shree Amit Diliprao chavan |
Non Government |
SDS | 2020 | 5.6 |
2020 – 2021 |
| 25 |
Design and Fabrication of Finger Mounted Illuminating Device Interfaced with Intra- oral Closed Circuit Camera for DentalProcedures |
Dr. Sudha Mattigatti |
Anand Life Sciences, Pharmaceutical Co. Belgaum |
Non Government |
Conservative Dentistry |
2020 | 2.5 |
2020 – 2021 |
| 26 |
Design, Development and Evaluation of Hospital Sewage Treatment Strategy with Special Reference to SARS-CoV-2 |
1).Dr. Jayant Pawar 2). Dr. Anupam Mukerjee 3). Dr. G. S. Karande |
B. G. Shirke, Construction Technology Pvt. Ltd, Pune |
Non Government |
1). Directorate of Research 2).ICMR-AIDS, Pune 3).Microbiology |
2020 | 30.25 |
2020 – 2021 |
| 27 |
A Clinical Trial to study effect of high dose vitamin C on clinical outcomes in patients infected with corona virus- 2019 (COVID-19) |
Dr. Archana Gautam |
B. G. Shirke, Construction Technology Pvt. Ltd, Pune |
Non Government |
Anaesthesia | 2020 | 19.85 |
2020 – 2021 |
Hon'ble Shree Jayawantrao Bhosale Innovation and Incubartion Center
ABOUT THE CENTRE
Hon’ble Shree Jaywantrao Bhosale Incubation and Innovation Center (JBIIC) is an interdisciplinary platform that creates a safe anchorage for novel ideas in the domain of medicine and allied sciences. With opportunities for individual researchers and group collaboration across all the disciplines of medicine, allied sciences, engineering, and technology, it’s a place that fosters a culture of innovation through the ideation, creation, testing, and validation of research concepts by developing prototypes for the growth of healthcare sector. This will establish a strong link between academics, industries, and end-users.
